(Q40617933)

22 September 2017

Reversible inhibition of cellular metabolism by ribavirin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A646339

https://api.crossref.org/works/10.1128/AAC.13.2.154

18 July 2022

Reversible Inhibition of Cellular Metabolism by Ribavirin (English)

1 reference

3 September 2023

1 reference

1 reference

https://api.crossref.org/works/10.1128/AAC.13.2.154

3 September 2023

author name string

A. Larsson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A646339

18 July 2022

K. Stenberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A646339

18 July 2022

B. Oberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A646339

18 July 2022

language of work or name

English

0 references

publication date

1 February 1978

1 reference

full work available at URL

22 September 2017

5

1 reference

based on heuristic

inferred from page(s)

https://europepmc.org/articles/PMC352205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A646339

https://europepmc.org/articles/PMC352205?pdf=render

18 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A646339

https://journals.asm.org/doi/pdf/10.1128/AAC.13.2.154

18 July 2022

1 reference

https://api.crossref.org/works/10.1128/AAC.13.2.154

Antimicrobial Agents and Chemotherapy

3 September 2023

published in

1 reference

22 September 2017

13

1 reference

22 September 2017

2

1 reference

22 September 2017

154-158

1 reference

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352205

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352205

The relationship between the metabolism of ribavirin and its proposed mechanism of action

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352205

The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352205

Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352205

17 June 2018

Identifiers

DOI

10.1128/AAC.13.2.154

1 reference

22 September 2017

1 reference

PMC publication ID

352205

22 September 2017

1 reference

PMC publication ID

352205